Lewis BB, Carter RA, Ling L, Leiner I, Taur Y, Kamboj M, Dubberke ER, Xavier J, Pamer EG.  2017.  Pathogenicity Locus, Core Genome, and Accessory Gene Contributions to Virulence.. MBio. 8(4)

Lewis BB, Carter RA, Pamer EG.  2016.  Bile acid sensitivity and in vivo virulence of clinical Clostridium difficile isolates.. Anaerobe. 41:32-36.

Abt MC, Lewis BB, Caballero S, Xiong H, Carter RA, Sušac B, Ling L, Leiner I, Pamer EG.  2015.  Innate Immune Defenses Mediated by Two ILC Subsets Are Critical for Protection against Acute Clostridium difficile Infection.. Cell Host Microbe. 18(1):27-37.

Lewis BB, Buffie CG, Carter RA, Leiner I, Toussaint NC, Miller LC, Gobourne A, Ling L, Pamer EG.  2015.  Loss of Microbiota-Mediated Colonization Resistance to Clostridium difficile Infection With Oral Vancomycin Compared With Metronidazole.. J Infect Dis. 212(10):1656-65.

Buffie CG, Bucci V, Stein RR, McKenney PT, Ling L, Gobourne A, No D, Liu H, Kinnebrew M, Viale A et al..  2015.  Precision microbiome reconstitution restores bile acid mediated resistance to Clostridium difficile.. Nature. 517(7533):205-8.

Kinnebrew MA, Lee YJoo, Jenq RR, Lipuma L, Littmann ER, Gobourne A, No D, van den Brink M, Pamer EG, Taur Y.  2014.  Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.. PLoS One. 9(3):e90158.